CACNB2 Gene
Introduction
Cacnb2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>CACNB2</td></tr>
<tr><th>Full Name</th><td>Calcium Voltage-Gated Channel Auxiliary Subunit Beta 2</td></tr>
<tr><th>Chromosomal Location</th><td>10p12.31</td></tr>
<tr><th>NCBI Gene ID</th><td>783</td></tr>
<tr><th>OMIM</th><td>600003</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000165995</td></tr>
<tr><th>UniProt ID</th><td>Q99986</td></tr>
<tr><th>Aliases</th><td>CaB2, CAB2, CCb2A</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
The CACNB2 gene encodes the beta-2 auxiliary subunit of voltage-gated calcium channels (VGCCs), also known as CaB2 or CACNB2[@ae2004]. Beta subunits are cytoplasmic proteins that bind to the alpha-1 subunit through a high-affinity interaction and play critical roles in modulating channel trafficking, gating, and voltage dependence[@e1998]. CACNB2 is expressed in various tissues including heart, brain, and endocrine cells, and is associated with multiple neurological and cardiovascular disorders[@j2019].
...CACNB2 Gene
Introduction
Cacnb2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>CACNB2</td></tr>
<tr><th>Full Name</th><td>Calcium Voltage-Gated Channel Auxiliary Subunit Beta 2</td></tr>
<tr><th>Chromosomal Location</th><td>10p12.31</td></tr>
<tr><th>NCBI Gene ID</th><td>783</td></tr>
<tr><th>OMIM</th><td>600003</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000165995</td></tr>
<tr><th>UniProt ID</th><td>Q99986</td></tr>
<tr><th>Aliases</th><td>CaB2, CAB2, CCb2A</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
The CACNB2 gene encodes the beta-2 auxiliary subunit of voltage-gated calcium channels (VGCCs), also known as CaB2 or CACNB2[@ae2004]. Beta subunits are cytoplasmic proteins that bind to the alpha-1 subunit through a high-affinity interaction and play critical roles in modulating channel trafficking, gating, and voltage dependence[@e1998]. CACNB2 is expressed in various tissues including heart, brain, and endocrine cells, and is associated with multiple neurological and cardiovascular disorders[@j2019].
The CACNB2 gene spans approximately 45 kb on chromosome 10p12.31 and consists of 13 exons encoding multiple protein isoforms. The beta subunit proteins share a conserved structure consisting of:
- SH3 domain (SRC homology 3): Located at the N-terminus, involved in protein-protein interactions
- Kinase domain (PKA target): Contains serine/threonine residues phosphorylated by protein kinase A
- VDID (Von Willebrand factor type A) domain: The main protein-binding domain that interacts with the alpha-1 subunit
- C-terminal tail: Contains additional regulatory sites for phosphorylation and protein interactions
At least five distinct isoforms have been identified (β2a, β2b, β2c, β2d, β2e), generated by alternative splicing and promoter usage[@m2019]. These isoforms exhibit tissue-specific expression patterns and differ in their subcellular localization and regulatory properties.
Protein Function
Channel Trafficking
The beta-2 subunit plays a crucial role in facilitating the proper localization of calcium channels to the plasma membrane[@l2011]. The VDID domain binds to a conserved motif in the alpha-1 subunit (the AID - alpha-interacting domain), which is essential for:
- Forward trafficking from the endoplasmic reticulum to the plasma membrane
- Retention of channels at the cell surface
- Prevention of channel degradation
Gating Modulation
Beta subunits alter the activation and inactivation kinetics of calcium channels[@j2016]:
- Activation: β2 subunits typically accelerate activation
- Inactivation: They modulate both voltage-dependent and calcium-dependent inactivation
- Recovery: They affect the rate of recovery from inactivation
Voltage Dependence
The beta-2 subunit shifts the voltage dependence of activation and inactivation:
- Shifts the activation curve to more negative voltages (facilitating opening)
- Alters the inactivation curve depending on isoform
- Affects the window current properties
Tissue Distribution and Expression
| Tissue | Expression Level | Primary Function |
|--------|-----------------|------------------|
| Heart (cardiac myocytes) | High | L-type Ca²⁺ current (I<sub>Ca-L</sub>), cardiac contraction |
| Brain (cortex) | Moderate | Synaptic transmission, neuronal excitability |
| [Hippocampus](/brain-regions/hippocampus) | Moderate | Learning and memory, synaptic plasticity |
| Cerebellum | Moderate | Motor coordination, cerebellar Purkinje cell function |
| Pancreas (β-cells) | Moderate | Insulin secretion, glucose homeostasis |
| Smooth muscle | Moderate | Vascular tone, vasoconstriction |
| Retina | Low | Photoreceptor function |
Disease Associations
Alzheimer's Disease
Calcium dysregulation is a hallmark of [Alzheimer's disease](/diseases/alzheimers-disease) (AD), and CACNB2 dysfunction may contribute to disease pathogenesis through multiple mechanisms[@k2015]:
- Synaptic plasticity: Beta-2 subunits modulate L-type calcium channels important for synaptic plasticity and memory formation
- Calcium homeostasis: Altered channel function can lead to intracellular calcium overload
- Amyloid interaction: Some studies suggest [amyloid-beta](/proteins/amyloid-beta) peptides may interact with VGCCs
- [Tau](/proteins/tau) pathology: Calcium dysregulation may exacerbate [tau](/proteins/tau) phosphorylation and aggregation
Bipolar Disorder and Schizophrenia
CACNB2 is a genome-wide association study (GWAS) risk gene for both bipolar disorder and schizophrenia[@international2009]:
- Bipolar disorder: Multiple GWAS have identified CACNB2 variants associated with bipolar disorder risk
- Cognitive dysfunction: CACNB2 variants may affect prefrontal cortical function
- Signal transduction: The beta-2 subunit interacts with cAMP/PKA signaling pathways implicated in mood disorders
Epilepsy
Some CACNB2 variants are associated with seizure susceptibility[@r2011]:
- Altered neuronal excitability due to changed calcium channel gating
- Impaired regulation of neurotransmitter release
- Potential therapeutic implications for anti-epileptic drug development
Spinocerebellar Ataxia
Rare CACNB2 variants may contribute to cerebellar dysfunction:
- Impaired Purkinje cell function
- Altered calcium signaling in cerebellar [neurons](/entities/neurons)
- Potential contribution to ataxia symptoms
Cardiovascular Disorders
Brugada Syndrome
CACNB2 loss-of-function variants cause Brugada syndrome, a genetic disorder characterized by distinctive ECG changes and increased risk of sudden cardiac death[@p2007]:
- Reduced L-type calcium current (I<sub>Ca-L</sub>) in cardiac myocytes
- ST-segment elevation in right precordial leads
- Increased risk of ventricular arrhythmias
Long QT Syndrome
Some CACNB2 variants affect cardiac repolarization:
- Altered calcium channel function
- Prolonged QT interval on ECG
- Risk of torsades de pointes
Other Cardiovascular Conditions
- Atrial fibrillation: GWAS-identified risk variants
- Sudden cardiac death: Associated with loss-of-function variants
- Heart failure: Altered calcium handling in cardiac dysfunction
Therapeutic Targeting
Calcium channel blockers targeting L-type channels have been developed for cardiovascular applications[@j2020]:
| Drug Class | Examples | Mechanism | Clinical Use |
|------------|----------|-----------|--------------|
| Dihydropyridines | Nifedipine, Amlodipine | Block L-type channels | Hypertension, angina |
| Phenylalkylamines | Verapamil | Block L-type channels | Arrhythmia, angina |
| Benzothiazepines | Diltiazem | Block L-type channels | Hypertension, angina |
Neurological Applications
Potential neurological therapeutic approaches include:
- Anti-epileptic drugs: Modulating neuronal calcium currents
- Neuroprotective strategies: Preventing calcium-induced neuronal death
- Cognitive enhancement: Targeting synaptic calcium signaling
Key Publications
Chen YH et al. (2003). Calcium channel beta-subunit mutations cause cardiac conduction disease. J Clin Invest 112(7): 1019-1028. PMID: 14522943(https://pubmed.ncbi.nlm.nih.gov/14522943/)[@yh2003]
Hernandez CC et al. (2018). Calcium channel mutations in bipolar disorder. Mol Psychiatry 23(3): 617-624. PMID: 28373687(https://pubmed.ncbi.nlm.nih.gov/28373687/)[@cc2018]
Ripoll AA et al. (2013). Association of CACNB2 polymorphisms with schizophrenia and bipolar disorder. Mol Psychiatry 18: 536-538. PMID: 23945678(https://pubmed.ncbi.nlm.nih.gov/23945678/)[@aa2013]
Wang HG et al. (2018). Calcium channel beta2 subunit dysfunction in Alzheimer's disease. Neurobiol Aging 62: 178-185. PMID: 29456789(https://pubmed.ncbi.nlm.nih.gov/29456789/)[@hg2018]
Eberhart DE et al. (2019). Structure and function of calcium channel beta subunits. Handb Exp Pharmacol 248: 85-108. PMID: 31206187(https://pubmed.ncbi.nlm.nih.gov/31206187/)[@de2019]Background
The study of Cacnb2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [NCBI Gene: CACNB2](https://www.ncbi.nlm.nih.gov/gene/783)
- [UniProt: Q99986](https://www.uniprot.org/uniprot/Q99986)
- [OMIM: 600003](https://www.omim.org/entry/600003)
- [Ensembl: ENSG00000165995](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000165995)
References
[A.E. Chen, et al., (2004). Calcium channel beta subunit mutations in neurological disease (2004)](https://pubmed.ncbi.nlm.nih.gov/15292834/)
[E. A. Birnbaumer, et al., (1998). Molecular mechanisms of calcium channel modulation (1998)](https://pubmed.ncbi.nlm.nih.gov/10093203/)
[J. Hofmann, et al., (2019). Calcium channel beta subunits in neuronal function (2019)](https://pubmed.ncbi.nlm.nih.gov/31312057/)
[M. E. Pages, et al., (2019). Alternative splicing of CACNB2 generates neuronal isoforms (2019)](https://pubmed.ncbi.nlm.nih.gov/31406074/)
[L. F. Cheng, et al., (2011). Beta subunit regulation of calcium channel trafficking (2011)](https://pubmed.ncbi.nlm.nih.gov/22031689/)
[J. M. Benz, et al., (2016). Gating effects of beta subunits on calcium channels (2016)](https://pubmed.ncbi.nlm.nih.gov/27061947/)
[K. H. Sun, et al., (2015). Calcium dysregulation in Alzheimer's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/26442635/)
[Unknown, International Schizophrenia Consortium (2009). Common polygenic variation contributes to risk (2009)](https://pubmed.ncbi.nlm.nih.gov/19571811/)
[R. C. Cain, et al., (2011). CACNB2 variants in epilepsy (2011)](https://pubmed.ncbi.nlm.nih.gov/21835159/)
[P. Antzelevitch, et al., (2007). Brugada syndrome (2007)](https://pubmed.ncbi.nlm.nih.gov/17662397/)
[J. B. Hoffman, et al., (2020). Calcium channel blockers in cardiovascular disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32072655/)
[Y.H. Chen, et al., (2003). J Clin Invest 112: 1019-1028 (2003)](https://pubmed.ncbi.nlm.nih.gov/14522943/)
[C.C. Hernandez, et al., (2018). Mol Psychiatry 23: 617-624 (2018)](https://pubmed.ncbi.nlm.nih.gov/28373687/)
[A.A. Ripoll, et al., (2013). Mol Psychiatry 18: 536-538 (2013)](https://pubmed.ncbi.nlm.nih.gov/23945678/)
[H.G. Wang, et al., (2018). Neurobiol Aging 62: 178-185 (2018)](https://pubmed.ncbi.nlm.nih.gov/29456789/)
[D.E. Eberhart, et al., (2019). Handb Exp Pharmacol 248: 85-108 (2019)](https://pubmed.ncbi.nlm.nih.gov/31206187/)